The Sick Times
  • Sections
    • Arts & Culture
    • Commentary
    • COVID-19
    • Health
    • International
    • Podcast
    • Policy & Advocacy
    • Science
  • About
    • Our team
    • Write for us
    • Transparency & policies
  • Resources
Newsletter
Donate
  • Department of Defense funds $8 million grant for Long COVID trials

    Department of Defense funds $8 million grant for Long COVID trials

    Betsy Ladyzhets

    A new U.S. clinical trials program called PROBE-PASC was announced on Friday at a Long COVID conference in Amsterdam. The program received initial funding of $8 million from a Department of Defense (DOD) grant. Read more…

Recent articles

  • National COVID-19 trends, September 1
    COVID-19
    Betsy Ladyzhets

    National COVID-19 trends, September 1

  • Research updates, September 1
    Science
    Miles W. Griffis

    Research updates, September 1

  • “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID
    Commentary
    Kelly Sealey

    “We’re going to stop the gaslighting right now”: How I’m fighting back as a Black woman with Long COVID

Get the latest Long COVID news and commentary

Sign up for our free newsletter, delivered every Tuesday! Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Check out our weekly podcast, Still Here

SpotifySpotifyApple PodcastsApple PodcastsPocketCastsPocketCastsiHeartRadioiHeartRadioRSSRSS

Trending

Department of Defense funds $8 million grant for Long COVID trialsDepartment of Defense funds $8 million grant for Long COVID trialsBetsy Ladyzhets
Long Covid advocates face challenges, potential discrimination with billboard campaignsLong Covid advocates face challenges, potential discrimination with billboard campaignsSimon Spichak
National COVID-19 trends, September 1National COVID-19 trends, September 1Betsy Ladyzhets
Research updates, September 1Research updates, September 1Miles W. Griffis
FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?FDA approves COVID-19 antiviral Xocova as PEP. But will it be accessible?Miles W. Griffis

Policy & Advocacy

Science

  • set of sample tubes arranged on pink surface
    February 13, 2024

    Research updates, February 13

  • heap of pills on yellow background
    February 6, 2024

    Research updates, February 6

  • January 30, 2024

    Research updates, January 30

  • Novel Coronavirus SARS-CoV-2–Colorized scanning electron
    January 23, 2024

    Research updates, January 23

  • Novel Coronavirus SARS-CoV-2–Transmission electron micrograph
    January 16, 2024

    Research updates, January 16

  • January 9, 2024

    New CDC data identify more than 5,000 Long Covid deaths, but tally is likely a significant undercount

Previous Page
1 … 34 35 36 37 38
Next Page

Covid-19

Health

Commentary

  • September 3, 2024

    As a doctor, I’m disappointed in my colleagues for ignoring Long COVID. I made a resource to educate them and the public.

  • August 27, 2024

    Even as a former executive assistant, managing care for Long COVID is a full-time job

  • A busy street in South Africa, with people walking and riding bikes near a supermarket
    August 1, 2024

    In South Africa, Long Covid is an afterthought to Tuberculosis

  • July 23, 2024

    This is what it feels like: Artist visualizes Long COVID symptoms

Previous Page
1 … 20 21 22 23 24 … 27
Next Page

The Sick Times is an independent news site founded by journalists Betsy Ladyzhets and Miles Griffis. We report on the Long COVID crisis, COVID-19, and infection-associated illnesses.

Contact:
editors@thesicktimes.org

PO Box 331009
Brooklyn, NY 11233

  1. Home
  2. About
  3. Newsletter
  4. Podcast
  5. Transparency & policies
  6. Write for us
  7. Resources
  8. Donate
  • Twitter
  • Instagram
  • YouTube
  • Facebook
  • Bluesky

Sign up for our free newsletter, delivered every Tuesday. Receive our latest stories, research updates, COVID-19 trends, and more.

Processing…
Success! You're on the list 🙂
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

© 2026 The Sick Times

Loading Comments...